We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.47%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$15.3B
AUM Growth
+$2.76B
(+22%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
12.55%
Top 10 Holdings %
Top 10 Hldgs %
45.98%
Holding
1,005
New
144
Increased
321
Reduced
458
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$335M |
| 2 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$122M |
| 3 |
JPMorgan Chase
JPM
|
+$113M |
| 4 |
Cheniere Energy
CQP
|
+$111M |
| 5 |
ENBL
ENABLE MIDSTREAM PARTNERS, LP
ENBL
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DM
Dominion Energy Midstream Ptr LP
DM
|
+$55.1M |
| 2 |
Navient
NAVI
|
+$47.5M |
| 3 |
Macy's
M
|
+$17.7M |
| 4 |
Occidental Petroleum
OXY
|
+$17M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 54.25% |
| 2 | Financials | 6.56% |
| 3 | Healthcare | 3.56% |
| 4 | Consumer Discretionary | 2.58% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SSR Mining
SSRM
$5.57B
| $8.28M | 0.05% |
838,794
+157,266
| +23% | +$1.6M |
|
127
Royal Gold
RGLD
$17.1B
| $8.23M | 0.05% |
88,696
-5,794
| -6% | -$519K |
|
|
PVG
128
DELISTED
PRETIUM RESOURCES INC.
PVG
| $7.99M | 0.05% |
1,088,683
-36,284
| -3% | -$259K |
|
|
B
129
Barrick Mining
B
$62.2B
| $7.83M | 0.05% |
596,422
+4,698
| +0.8% | +$61.6K |
|
130
Amazon
AMZN
$2.5T
| $7.63M | 0.05% |
+89,800
| New | +$7.13M |
|
131
Dominion Energy
D
$62.5B
| $7.61M | 0.05% |
111,558
+28,005
| +34% | +$1.82M |
|
|
KYNB
132
Kyntra Bio
KYNB
$28.5M
| $7.55M | 0.05% |
4,827
+427
| +10% | +$557K |
|
|
LOXO
133
DELISTED
Loxo Oncology, Inc
LOXO
| $7.54M | 0.05% |
43,438
+3,399
| +8% | +$511K |
|
134
Sibanye-Stillwater
SBSW
$5.92B
| $7.49M | 0.05% |
3,094,552
+2,264,955
| +273% | +$6.98M |
|
135
Alamos Gold
AGI
$12.4B
| $7.36M | 0.05% |
1,293,780
-634,334
| -33% | -$3.48M |
|
136
First Majestic Silver
AG
$8.05B
| $7.34M | 0.05% |
961,782
-12,011
| -1% | -$84.1K |
|
137
Fortuna Silver Mines
FSM
$2.59B
| $7.14M | 0.05% |
1,256,592
-85,563
| -6% | -$479K |
|
138
United Therapeutics
UTHR
$26.3B
| $7.12M | 0.05% |
+62,888
| New | +$6.91M |
|
139
Agios Pharmaceuticals
AGIO
$2.16B
| $7.02M | 0.05% |
83,297
+8,580
| +11% | +$748K |
|
140
Compañía de Minas Buenaventura
BVN
$7.85B
| $6.93M | 0.05% |
508,825
-10,344
| -2% | -$161K |
|
|
GLIBA
141
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $6.82M | 0.04% |
151,200
+3,500
| +2% | +$161K |
|
142
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $6.79M | 0.04% |
63,588
+1,760
| +3% | +$192K |
|
|
LKFT
143
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $6.76M | 0.04% |
73,389
+5,234
| +8% | +$508K |
|
144
Danaher
DHR
$135B
| $6.76M | 0.04% |
77,310
+9,560
| +14% | +$852K |
|
|
TARO
145
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6.7M | 0.04% |
57,924
+4,138
| +8% | +$455K |
|
146
Kinder Morgan
KMI
$73.1B
| $6.68M | 0.04% |
378,311
-8,354
| -2% | -$137K |
|
|
MIC
147
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $6.51M | 0.04% |
154,336
+13,568
| +10% | +$533K |
|
148
Ares Capital
ARCC
$13.5B
| $6.43M | 0.04% |
390,675
+14,200
| +4% | +$233K |
|
149
Ligand Pharmaceuticals
LGND
$6.02B
| $6.38M | 0.04% |
49,347
+3,974
| +9% | +$443K |
|
150
CenterPoint Energy
CNP
$29.1B
| $6.34M | 0.04% |
228,786
+18,031
| +9% | +$473K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, ALPS Advisors held 1,005 positions worth $15.3B, up 22% from $12.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
ALPS Advisors deployed $1.92B of net new capital in Q2 2018, opening 144 new positions and adding to 321 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,144 shares worth $323M.
By sector, the portfolio is most concentrated in Energy at 54% of assets, down from 56% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dominion Energy Midstream Ptr LP, an estimated $55.1M trimmed.
- ALPS Advisors's largest Q2 2018 buy was Berkshire Hathaway Class A: 1,144 shares worth $323M.
- ALPS Advisors added most to JPMorgan Chase in Q2 2018, an estimated $113M increase.
- ALPS Advisors's biggest Q2 2018 reduction was Dominion Energy Midstream Ptr LP, cutting an estimated $55.1M.
- ALPS Advisors fully exited BeOne Medicines Ltd in Q2 2018, selling an estimated $9.35M.
- ALPS Advisors's ten largest holdings make up 46% of its $15.3B portfolio in Q2 2018.
- ALPS Advisors opened 144 new positions and closed 80 in Q2 2018.
- ALPS Advisors's portfolio value rose 22% quarter-over-quarter to $15.3B.
Based on ALPS Advisors's 13F filing for Q2 2018, filed 25 Jul 2018.